Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With Tecfidera, Biogen Idec Delivers Best MS Product Launch Yet

Jul 25 2013

• By Stacy Lawrence

Related Content

Biogen Idec Undercuts <em>Gilenya</em> With $55,000 Yearly Price For <em>Tecfidera</em>

Apr 01 2013

Biogen Idec’s <em>Tecfidera</em> Goes To Market With Claim For Delay Of Disability Progression

Mar 28 2013

Biogen Leans On Plegridy To Help Extend The Life Of Avonex

Mar 20 2013

As Majority Of U.S. Patients Tested For JCV, Tysabri Sales Rise, Elan Says

Feb 08 2012

Related Companies

Biogen, Inc.

Novartis AG

Additional Topics

United States Europe Japan Asia Pacific Launches BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window